Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.44%
SPX
-0.28%
IXIC
-0.28%
FTSE
-2.35%
N225
-3.38%
AXJO
-0.36%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
ptct
PTC Therapeutics
NASDAQ: PTCT
+0.11 (+0.16%)
67.11
USD
At close at Mar 19, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
5.38B
Dividend Yield
0.00%
P/E Ratio
7.88
EPS
-4.73
Revenue
806.78M
Avg. Volume
1.20M

Recently from Cashu

publisher logo
Cashu

PTC Therapeutics Enhances Employee Engagement with New Stock Options and RSUs Package

4 days ago
publisher logo
Cashu

PTC Therapeutics Boosts Talent Acquisition with Stock Options and RSUs for New Employees

6 days ago
publisher logo
Cashu

UniQure Faces FDA Scrutiny Over Huntington's Gene Therapy Amid Controversy and Ethical Concerns

12 days ago

About

What does PTCT do?
PTC Therapeutics, headquartered in Warren, New Jersey, develops medicines for rare disorders and has two key products for Duchenne muscular dystrophy. The company went public in 2013 and employs 988 people.
Sector
💻 Health Care
IPO
CEO
Employees
991
Headquarters
New Jersey, USA
Website
http://www.ptcbio.com
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.